Postdoctoral Fellow-MSH-12600-140 - The Mount Sinai Health System
New York, NY
About the Job
JOB DESCRIPTION
Title: Postdoctoral Research Fellow
Salary:
Department: Cardiology
Physical work location: 1190 5 th Avenue / GP1C Reading Room and Atran Berg 8 th Floor CV Research Lab
Name PI or Supervisor: Gina LaRocca, MD (gina.larocca@mountsinai.org)
Web link to Lab:https://icahn.mssm.edu/education/residencies-fellowships/list/advanced-cardiac-imaging
Web link to Department: https://www.mountsinai.org/care/heart?utm_source=google&utm_medium=cpc&utm_campaign=mshs-systemwidecardiology-ma&utm_content=sem&_vsrefdom=mchxsearch&campaign_id=701VM000005FQ49YAG&gclid=CjwKCAjw1emzBhB8EiwAHwZZxZaVx-znrYXVAbd6jM51XyFcBxCUPNo6bpoKStYOQ3hmP_Ok3P1c2hoCY6sQAvD_BwE&gclsrc=aw.ds
Administrative Contact: John Persaud (john.persaud@mssm.edu)
RESPONSIBILITIES
Details of Research Project:
Will be involved in several research projects. Will participate in cardiac magnetic resonance (CMR) and computed tomography (CT) research regarding evaluation of cardiovascular diseases (see below). Responsibilities in this research are collection of data and image analysis. No element of patient care services will be involved.
-Prognostic value of cardiac CMR in cardiac amyloidosis
Cardiac amyloidosis is a disease in which the extracellular space in the heart is occupied by a fibrillar protein called amyloid. Amyloid can be formed by a large number of precursor proteins.
There is a need to describe cardiac MRI parameters that relate to the prognosis of the disease and others that allow to distinguish the two most frequent types of amyloidosis.
-Prognostic value of cardiac magnetic resonance in patients with sarcoidosis
Sarcoidosis is a multi-systemic inflammatory disorder of unknown etiology. Sarcoidosis can affect the heart. We want to evaluate our experience regarding prevalence and prognostic significance of CMR abnormalities in patients with sarcoidosis.
-The Impact of Corona Virus Disease - 2019 on Coronary Atherosclerosis: Rationale and Design of the COrona VIrus Disease-2019 Computed Tomography (COVID-CT) Registry
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus which causes the corona virus disease - 2019 (COVID-19) has become a leading cause of death with substantial evidence that patients with pre-existing coronary artery disease (CAD) have an increased risk of serious illness and mortality following infection. The COVID-CT registry will assess whether systemic inflammation results in marked progression of coronary atherosclerotic plaque in patients with previously defined anatomic CAD on coronary computed tomographic angiography
Technical Duties: (include any protocols)
Image analyses of the CMR and CT will be performed locally by Sinai investigators for the purpose of this research. There will be no further testing performed on the patients, only analysis of already available images and collection of already available clinical data.
QUALIFICATIONS
Educational and other Requirements for the position:
Cardiologist with extensive research experience in the field of cardiology, as evidenced by the last year and a half he has spent at our center (Mount Sinai) doing research on cardiomyopathies.
Experience Required:
MD and cardiologist with experience in cardiovascular research
Goals/Outcomes of the Research Project:
-Prognostic value of cardiac CMR in cardiac amyloidosis
The aim of our study will be to analyze the prognostic role of cardiac CMR and to compare their predictive value in patients with amyloidosis, as well as the usefulness of cardiac CMR in the differentiation of amyloidosis types.
-Prognostic value of cardiac magnetic resonance in patients with sarcoidosis
The aim of our study will be to evaluate associations of CMR-based presence and/or severity of cardiac sarcoidosis
--The Impact of Corona Virus Disease - 2019 on Coronary Atherosclerosis: Rationale and Design of the COrona VIrus Disease-2019 Computed Tomography (COVID-CT) Registry
The primary study objective of the COVID-CT registry is to evaluate whether in patients with pre-existent CAD on CT, infection with SARS-CoV-2 results in marked progression of total coronary atherosclerotic plaque, including increased luminal stenosis and positive remodeling, compared to patients not infected by COVID-19.
SPOC-UAW Local 4100 at Icahn School of Medicine (Post Docs), 821 - Cardiology - ISM, Icahn School of Medicine
EOE Minorities/Women/Disabled/Veterans
The Mount Sinai Health System is an equal opportunity employer. We comply with applicable Federal civil rights laws and does not discriminate, exclude, or treat people differently on the basis of race, color, national origin, age, religion, disability, sex, sexual orientation, gender identity, or gender expression. We are passionately committed to addressing racism and its effects on our faculty, staff, students, trainees, patients, visitors, and the communities we serve. Our goal is for Mount Sinai to become an anti-racist health care and learning institution that intentionally addresses structural racism.?
ABOUT US
Strength Through Diversity
The Mount Sinai Health System believes that diversity, equity, and inclusion are key drivers for excellence. We share a common devotion to delivering exceptional patient care. When you join us, you become a part of Mount Sinai’s unrivaled record of achievement, education, and advancement as we revolutionize medicine together. We invite you to participate actively as a part of the Mount Sinai Health System team by:
+ Using a lens of equity in all aspects of patient care delivery, education, and research to promote policies and practices to allow opportunities for all to thrive and reach their potential.
+ Serving as a role model confronting racist, sexist, or other inappropriate actions by speaking up, challenging exclusionary organizational practices, and standing side-by-side in support of colleagues who experience discrimination.
+ Inspiring and fostering an environment of anti-racist behaviors among and between departments and co-workers.
At Mount Sinai, our leaders strive to learn, empower others, and embrace change to further advance equity and improve the well-being of staff, patients, and the organization. We expect our leaders to embrace anti-racism, create a collaborative and respectful environment, and constructively disrupt the status quo to improve the system and enhance care for our patients. We work hard to create an inclusive, welcoming and nurturing work environment where all feel they are valued, belong and are able to advance professionally.
Explore more about this opportunity and how you can help us write a new chapter in our history!
“About the Mount Sinai Health System:
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is ranked No. 14 nationwide in National Institutes of Health funding and in the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.
The Mount Sinai Health System is an equal opportunity employer. We comply with applicable Federal civil rights laws and does not discriminate, exclude, or treat people differently on the basis of race, color, national origin, age, religion, disability, sex, sexual orientation, gender identity, or gender expression. We are passionately committed to addressing racism and its effects on our faculty, staff, students, trainees, patients, visitors, and the communities we serve. Our goal is for Mount Sinai to become an anti-racist health care and learning institution that intentionally addresses structural racism.”
EOE Minorities/Women/Disabled/Veterans
Requisition ID : 3019076
Title: Postdoctoral Research Fellow
Salary:
Department: Cardiology
Physical work location: 1190 5 th Avenue / GP1C Reading Room and Atran Berg 8 th Floor CV Research Lab
Name PI or Supervisor: Gina LaRocca, MD (gina.larocca@mountsinai.org)
Web link to Lab:https://icahn.mssm.edu/education/residencies-fellowships/list/advanced-cardiac-imaging
Web link to Department: https://www.mountsinai.org/care/heart?utm_source=google&utm_medium=cpc&utm_campaign=mshs-systemwidecardiology-ma&utm_content=sem&_vsrefdom=mchxsearch&campaign_id=701VM000005FQ49YAG&gclid=CjwKCAjw1emzBhB8EiwAHwZZxZaVx-znrYXVAbd6jM51XyFcBxCUPNo6bpoKStYOQ3hmP_Ok3P1c2hoCY6sQAvD_BwE&gclsrc=aw.ds
Administrative Contact: John Persaud (john.persaud@mssm.edu)
RESPONSIBILITIES
Details of Research Project:
Will be involved in several research projects. Will participate in cardiac magnetic resonance (CMR) and computed tomography (CT) research regarding evaluation of cardiovascular diseases (see below). Responsibilities in this research are collection of data and image analysis. No element of patient care services will be involved.
-Prognostic value of cardiac CMR in cardiac amyloidosis
Cardiac amyloidosis is a disease in which the extracellular space in the heart is occupied by a fibrillar protein called amyloid. Amyloid can be formed by a large number of precursor proteins.
There is a need to describe cardiac MRI parameters that relate to the prognosis of the disease and others that allow to distinguish the two most frequent types of amyloidosis.
-Prognostic value of cardiac magnetic resonance in patients with sarcoidosis
Sarcoidosis is a multi-systemic inflammatory disorder of unknown etiology. Sarcoidosis can affect the heart. We want to evaluate our experience regarding prevalence and prognostic significance of CMR abnormalities in patients with sarcoidosis.
-The Impact of Corona Virus Disease - 2019 on Coronary Atherosclerosis: Rationale and Design of the COrona VIrus Disease-2019 Computed Tomography (COVID-CT) Registry
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus which causes the corona virus disease - 2019 (COVID-19) has become a leading cause of death with substantial evidence that patients with pre-existing coronary artery disease (CAD) have an increased risk of serious illness and mortality following infection. The COVID-CT registry will assess whether systemic inflammation results in marked progression of coronary atherosclerotic plaque in patients with previously defined anatomic CAD on coronary computed tomographic angiography
Technical Duties: (include any protocols)
Image analyses of the CMR and CT will be performed locally by Sinai investigators for the purpose of this research. There will be no further testing performed on the patients, only analysis of already available images and collection of already available clinical data.
QUALIFICATIONS
Educational and other Requirements for the position:
Cardiologist with extensive research experience in the field of cardiology, as evidenced by the last year and a half he has spent at our center (Mount Sinai) doing research on cardiomyopathies.
Experience Required:
MD and cardiologist with experience in cardiovascular research
Goals/Outcomes of the Research Project:
-Prognostic value of cardiac CMR in cardiac amyloidosis
The aim of our study will be to analyze the prognostic role of cardiac CMR and to compare their predictive value in patients with amyloidosis, as well as the usefulness of cardiac CMR in the differentiation of amyloidosis types.
-Prognostic value of cardiac magnetic resonance in patients with sarcoidosis
The aim of our study will be to evaluate associations of CMR-based presence and/or severity of cardiac sarcoidosis
--The Impact of Corona Virus Disease - 2019 on Coronary Atherosclerosis: Rationale and Design of the COrona VIrus Disease-2019 Computed Tomography (COVID-CT) Registry
The primary study objective of the COVID-CT registry is to evaluate whether in patients with pre-existent CAD on CT, infection with SARS-CoV-2 results in marked progression of total coronary atherosclerotic plaque, including increased luminal stenosis and positive remodeling, compared to patients not infected by COVID-19.
SPOC-UAW Local 4100 at Icahn School of Medicine (Post Docs), 821 - Cardiology - ISM, Icahn School of Medicine
EOE Minorities/Women/Disabled/Veterans
The Mount Sinai Health System is an equal opportunity employer. We comply with applicable Federal civil rights laws and does not discriminate, exclude, or treat people differently on the basis of race, color, national origin, age, religion, disability, sex, sexual orientation, gender identity, or gender expression. We are passionately committed to addressing racism and its effects on our faculty, staff, students, trainees, patients, visitors, and the communities we serve. Our goal is for Mount Sinai to become an anti-racist health care and learning institution that intentionally addresses structural racism.?
ABOUT US
Strength Through Diversity
The Mount Sinai Health System believes that diversity, equity, and inclusion are key drivers for excellence. We share a common devotion to delivering exceptional patient care. When you join us, you become a part of Mount Sinai’s unrivaled record of achievement, education, and advancement as we revolutionize medicine together. We invite you to participate actively as a part of the Mount Sinai Health System team by:
+ Using a lens of equity in all aspects of patient care delivery, education, and research to promote policies and practices to allow opportunities for all to thrive and reach their potential.
+ Serving as a role model confronting racist, sexist, or other inappropriate actions by speaking up, challenging exclusionary organizational practices, and standing side-by-side in support of colleagues who experience discrimination.
+ Inspiring and fostering an environment of anti-racist behaviors among and between departments and co-workers.
At Mount Sinai, our leaders strive to learn, empower others, and embrace change to further advance equity and improve the well-being of staff, patients, and the organization. We expect our leaders to embrace anti-racism, create a collaborative and respectful environment, and constructively disrupt the status quo to improve the system and enhance care for our patients. We work hard to create an inclusive, welcoming and nurturing work environment where all feel they are valued, belong and are able to advance professionally.
Explore more about this opportunity and how you can help us write a new chapter in our history!
“About the Mount Sinai Health System:
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is ranked No. 14 nationwide in National Institutes of Health funding and in the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.
The Mount Sinai Health System is an equal opportunity employer. We comply with applicable Federal civil rights laws and does not discriminate, exclude, or treat people differently on the basis of race, color, national origin, age, religion, disability, sex, sexual orientation, gender identity, or gender expression. We are passionately committed to addressing racism and its effects on our faculty, staff, students, trainees, patients, visitors, and the communities we serve. Our goal is for Mount Sinai to become an anti-racist health care and learning institution that intentionally addresses structural racism.”
EOE Minorities/Women/Disabled/Veterans
Requisition ID : 3019076
Source : The Mount Sinai Health System
